Citations

Citations to this article as recorded by  

• Diagnostic significance and cytological features of NUT carcinoma by EBUS‐FNA, a case report and literature review
  Yaping Ju, Miriam Velazquez, Andy Sherrod, Tiannan Wang
  Cytopathology.2024;[Epub]     CrossRef
• BRD3‐NUTM1‐expressing NUT carcinoma of lung on endobronchial ultrasound‐guided transbronchial needle aspiration cytology, a diagnostic pitfall
  Sameer Chhetri Aryal, Shereen Zia, Shannon Rodgers, Yulei Shen, Kyle Perry, Lisi Yuan
  Diagnostic Cytopathology.2022;[Epub]     CrossRef
• Nuclear protein of the testis midline carcinoma of the thorax
  Ayae Saiki, Keita Sakamoto, Yuan Bee, Takehiro Izumo
  Japanese Journal of Clinical Oncology.2022; 52(6): 531.     CrossRef
• Approach to Mediastinal Fine Needle Aspiration Cytology
  Zaibo Li, Huihong Xu, Fang Fan
  Advances in Anatomic Pathology.2022; 29(6): 337.     CrossRef
• Diagnosis, Treatment and Prognosis of Primary Pulmonary NUT Carcinoma: A Literature Review
  Jiaqian Yuan, Zhili Xu, Yong Guo
  Current Oncology.2022; 29(10): 6807.     CrossRef
• Case report: Immunovirotherapy as a novel add-on treatment in a patient with thoracic NUT carcinoma
  Linus D. Kloker, Branko Calukovic, Katrin Benzler, Alexander Golf, Sebastian Böhm, Sven Günther, Marius Horger, Simone Haas, Susanne Berchtold, Julia Beil, Mary E. Carter, Tina Ganzenmueller, Stephan Singer, Abbas Agaimy, Robert Stöhr, Arndt Hartmann, Tho
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Cytomorphology of primary pulmonary NUT carcinoma in different cytology preparations
  Rimlee Dutta, Aruna Nambirajan, Saurabh Mittal, Sinchita Roy‐Chowdhuri, Deepali Jain
  Cancer Cytopathology.2021; 129(1): 53.     CrossRef
• Update on genetically defined lung neoplasms: NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumors
  Kyriakos Chatzopoulos, Jennifer M. Boland
  Virchows Archiv.2021; 478(1): 21.     CrossRef
• Immunotherapy and Targeting the Tumor Microenvironment: Current Place and New Insights in Primary Pulmonary NUT Carcinoma
  Xiang Li, Hui Shi, Wei Zhang, Chong Bai, Miaoxia He, Na Ta, Haidong Huang, Yunye Ning, Chen Fang, Hao Qin, Yuchao Dong
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Prevalence of NUT carcinoma in head and neck: Analysis of 362 cases with literature review
  Taebum Lee, Junhun Cho, Chung‐Hwan Baek, Young‐Ik Son, Han‐Sin Jeong, Man Ki Chung, Sang Duk Hong, Yong Chan Ahn, Dong Ryul Oh, Jae Myoung Noh, Keunchil Park, Myung‐Ju Ahn, Hyung‐Jin Kim, Yi Kyung Kim, Young Hyeh Ko
  Head & Neck.2020; 42(5): 924.     CrossRef
• Lung nuclear protein in testis carcinoma in an elderly Korean woman: A case report with cytohistological analysis
  Hwa Jin Cho, Hyun‐Kyung Lee
  Thoracic Cancer.2020; 11(6): 1724.     CrossRef
• Clinicopathological characteristics of primary lung nuclear protein in testis carcinoma: A single‐institute experience of 10 cases
  Yoon Ah Cho, Yoon‐La Choi, Inwoo Hwang, Kyungjong Lee, Jong Ho Cho, Joungho Han
  Thoracic Cancer.2020; 11(11): 3205.     CrossRef

Citations

Citations to this article as recorded by  

• Artificial Intelligence in Lung Cancer Imaging: From Data to Therapy
  Michaela Cellina, Giuseppe De Padova, Nazarena Caldarelli, Dario Libri, Maurizio Cè, Carlo Martinenghi, Marco Alì, Sergio Papa, Gianpaolo Carrafiello
  Critical Reviews™ in Oncogenesis.2024; 29(2): 1.     CrossRef
• Artificial Intelligence for Cardiothoracic Imaging: Overview of Current and Emerging Applications
  Bruno Hochhegger, Romulo Pasini, Alysson Roncally Carvalho, Rosana Rodrigues, Stephan Altmayer, Leonardo Kayat Bittencourt, Edson Marchiori, Reza Forghani
  Seminars in Roentgenology.2023; 58(2): 184.     CrossRef
• Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study
  Diego F. Chamorro, Andrés F. Cardona, July Rodríguez, Alejandro Ruiz-Patiño, Oscar Arrieta, Darwin A. Moreno-Pérez, Leonardo Rojas, Zyanya Lucia Zatarain-Barrón, Dora V. Ardila, Lucia Viola, Gonzalo Recondo, Juan B. Blaquier, Claudio Martín, Luis Raez, Su
  Targeted Oncology.2023; 18(3): 425.     CrossRef
• Histone deacetylase inhibitor belinostat regulates metabolic reprogramming in killing KRAS‐mutant human lung cancer cells
  Rebecca M. Peter, Md. Shahid Sarwar, Sarah Z. Mostafa, Yujue Wang, Xiaoyang Su, Ah‐Ng Kong
  Molecular Carcinogenesis.2023; 62(8): 1136.     CrossRef
• Differential Distribution of Brain Metastases from Non-Small Cell Lung Cancer Based on Mutation Status
  Bihong T. Chen, Taihao Jin, Ningrong Ye, Sean W. Chen, Russell C. Rockne, Stephanie Yoon, Isa Mambetsariev, Ebenezer Daniel, Ravi Salgia
  Brain Sciences.2023; 13(7): 1057.     CrossRef
• Clinicopathological features and prognostic significance of pulmonary adenocarcinoma with signet ring cell components: meta-analysis and SEER analysis
  Yang Tan, Ying-he Huang, Jia-wen Xue, Rui Zhang, Run Liu, Yan Wang, Zhen-Bo Feng
  Clinical and Experimental Medicine.2023; 23(8): 4341.     CrossRef
• Ganoderma microsporum immunomodulatory protein as an extracellular epidermal growth factor receptor (EGFR) degrader for suppressing EGFR-positive lung cancer cells
  Wei-Jyun Hua, Hsin Yeh, Zhi-Hu Lin, Ai-Jung Tseng, Li-Chen Huang, Wei-Lun Qiu, Tsung-Hsi Tu, Ding-Han Wang, Wei-Hung Hsu, Wei-Lun Hwang, Tung-Yi Lin
  Cancer Letters.2023; 578: 216458.     CrossRef
• Next generation sequencing for detection of EGFR alterations in NSCLC: is more better?
  Ullas Batra, Shrinidhi Nathany, Mansi Sharma, Parveen Jain, Anurag Mehta
  Journal of Clinical Pathology.2022; 75(3): 164.     CrossRef
• Enkurin domain containing 1 (ENKD1) regulates the proliferation, migration and invasion of non‐small cell lung cancer cells
  Ting Song, Peng Zhou, Chunjiao Sun, Na He, Haixia Li, Jie Ran, Jun Zhou, Yue Wu, Min Liu
  Asia-Pacific Journal of Clinical Oncology.2022;[Epub]     CrossRef
• Targeting Mutant Kirsten Rat Sarcoma Viral Oncogene Homolog in Non-Small Cell Lung Cancer: Current Difficulties, Integrative Treatments and Future Perspectives
  Jia-Xin Li, Run-Ze Li, Lin-Rui Ma, Peng Wang, Dong-Han Xu, Jie Huang, Li-Qi Li, Ling Tang, Ying Xie, Elaine Lai-Han Leung, Pei-Yu Yan
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Histone H3K9 methyltransferase SETDB1 augments invadopodia formation to promote tumor metastasis
  Shuhei Ueshima, Jia Fang
  Oncogene.2022; 41(24): 3370.     CrossRef
• ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer
  A. Passaro, N. Leighl, F. Blackhall, S. Popat, K. Kerr, M.J. Ahn, M.E. Arcila, O. Arrieta, D. Planchard, F. de Marinis, A.M. Dingemans, R. Dziadziuszko, C. Faivre-Finn, J. Feldman, E. Felip, G. Curigliano, R. Herbst, P.A. Jänne, T. John, T. Mitsudomi, T.
  Annals of Oncology.2022; 33(5): 466.     CrossRef
• Molecular Targets in Lung Cancer: Study of the Evolution of Biomarkers Associated with Treatment with Tyrosine Kinase Inhibitors—Has NF1 Tumor Suppressor a Key Role in Acquired Resistance?
  Begoña O. Alen, Lara S. Estévez-Pérez, María Teresa Hermida-Romero, Ana Reguera-Arias, Rosario García-Campelo, Mercedes de la Torre-Bravos, Ángel Concha
  Cancers.2022; 14(14): 3323.     CrossRef
• Analytical and clinical validation of a custom 15-gene next-generation sequencing panel for the evaluation of circulating tumor DNA mutations in patients with advanced non-small-cell lung cancer
  Yock Ping Chow, Norziha Zainul Abidin, Ken Siong Kow, Lye Mun Tho, Chieh Lee Wong, Rama Krishna Kancha
  PLOS ONE.2022; 17(10): e0276161.     CrossRef
• Potential Therapeutic Strategy for EGFR-Mutant Lung Cancer With Concomitant EML4-ALK Rearrangement—Combination of EGFR Tyrosine Kinase Inhibitors and ALK Inhibitors
  Ming-Hung Huang, Jih-Hsiang Lee, Pei-Shan Hung, James Chih-Hsin Yang
  JTO Clinical and Research Reports.2022; 3(11): 100405.     CrossRef
• Artificial Intelligence in Lung Cancer Imaging: Unfolding the Future
  Michaela Cellina, Maurizio Cè, Giovanni Irmici, Velio Ascenti, Natallia Khenkina, Marco Toto-Brocchi, Carlo Martinenghi, Sergio Papa, Gianpaolo Carrafiello
  Diagnostics.2022; 12(11): 2644.     CrossRef
• A single center analysis of first-line treatment in advanced KRAS mutant non-small cell lung cancer: real-world practice
  Yanxia Liu, Yuan Gao, Ying Wang, Cong Zhao, Zhiyun Zhang, Baolan Li, Tongmei Zhang
  BMC Cancer.2022;[Epub]     CrossRef
• High frequency of KRAS and EGFR mutation profiles in BRAF-negative thyroid carcinomas in Indonesia
  Didik Setyo Heriyanto, Vincent Laiman, Nikko Vanda Limantara, Widyan Putra Anantawikrama, Fara Silvia Yuliani, Rita Cempaka, Sumadi Lukman Anwar
  BMC Research Notes.2022;[Epub]     CrossRef
• Targeted next-generation sequencing for cancer-associated gene mutation and copy number detection in 206 patients with non–small-cell lung cancer
  Songbai Zheng, Xiaodan Wang, Ying Fu, Beibei Li, Jianhua Xu, Haifang Wang, Zhen Huang, Hui Xu, Yurong Qiu, Yaozhou Shi, Kui Li
  Bioengineered.2021; 12(1): 791.     CrossRef
• How mathematical modeling could contribute to the quantification of metastatic tumor burden under therapy: insights in immunotherapeutic treatment of non-small cell lung cancer
  Pirmin Schlicke, Christina Kuttler, Christian Schumann
  Theoretical Biology and Medical Modelling.2021;[Epub]     CrossRef
• A case of concomitant EGFR/ALK alteration against a mutated EGFR background in early-stage lung adenocarcinoma
  Ki-Chang Lee, Jiwon Koh, Doo Hyun Chung, Yoon Kyung Jeon
  Journal of Pathology and Translational Medicine.2021; 55(2): 139.     CrossRef
• Malfeasance of KRAS mutations in carcinogenesis
  Rupal Tripathi, Shrinidhi Nathany, Anurag Mehta, Ullas Batra, Sakshi Mattoo, Mansi Sharma
  Clinical and Experimental Medicine.2021; 21(3): 439.     CrossRef
• Detection of Low-Frequency KRAS Mutations in cfDNA From EGFR-Mutated NSCLC Patients After First-Line EGFR Tyrosine Kinase Inhibitors
  Giorgia Nardo, Jessica Carlet, Ludovica Marra, Laura Bonanno, Alice Boscolo, Alessandro Dal Maso, Andrea Boscolo Bragadin, Stefano Indraccolo, Elisabetta Zulato
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma
  Valerio Gristina, Maria La Mantia, Antonio Galvano, Sofia Cutaia, Nadia Barraco, Marta Castiglia, Alessandro Perez, Marco Bono, Federica Iacono, Martina Greco, Katia Calcara, Valentina Calò, Sergio Rizzo, Lorena Incorvaia, Maria Chiara Lisanti, Giulia San
  Journal of Molecular Pathology.2021; 2(2): 173.     CrossRef
• Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging Markets
  Mercedes L Dalurzo, Alejandro Avilés-Salas, Fernando Augusto Soares, Yingyong Hou, Yuan Li, Anna Stroganova, Büge Öz, Arif Abdillah, Hui Wan, Yoon-La Choi
  OncoTargets and Therapy.2021; Volume 14: 4671.     CrossRef
• Untangling the KRAS mutated lung cancer subsets and its therapeutic implications
  Kulshrestha Ritu, Pawan Kumar, Amit Singh, K. Nupur, Sonam Spalgias, Parul Mrigpuri, Rajkumar
  Molecular Biomedicine.2021;[Epub]     CrossRef
• Lorlatinib Induces Durable Disease Stabilization in a Pancreatic Cancer Patient with a ROS1 p.L1950F Mutation: Case Report
  Janna-Lisa Velthaus, Peter Iglauer, Ronald Simon, Carsten Bokemeyer, Peter Bannas, Niklas Beumer, Charles D. Imbusch, Eray Goekkurt, Sonja Loges
  Oncology Research and Treatment.2021; 44(9): 495.     CrossRef
• Proteasome-dependent degradation of Smad7 is critical for lung cancer metastasis
  Lu Tong, Shihui Shen, Quan Huang, Junjiang Fu, Tianzhen Wang, Linian Pan, Pei Zhang, Geng Chen, Tingmei Huang, Ke Li, Qingwu Liu, Shaofang Xie, Xiao Yang, Robb E. Moses, Xiaotao Li, Lei Li
  Cell Death & Differentiation.2020; 27(6): 1795.     CrossRef
• Circulating cell-free DNA as a diagnostic and prognostic biomarker for non-small-cell lung cancer: a systematic review and meta-analysis
  Zhoumiao Chen, Huiwen Miao, Qingxin Zeng, Shaohua Xu, Zhao Chen, Kai Liu
  Biomarkers in Medicine.2020; 14(7): 587.     CrossRef
• Influence of EGFR-activating mutations on sensitivity to tyrosine kinase inhibitors in a KRAS mutant non-small cell lung cancer cell line
  Yoshinori Tsukumo, Mikihiko Naito, Takayoshi Suzuki, Srikumar Chellappan
  PLOS ONE.2020; 15(3): e0229712.     CrossRef
• KRAS oncogene may be another target conquered in non‐small cell lung cancer (NSCLC)
  Hanxiao Chen, Jun Zhao
  Thoracic Cancer.2020; 11(12): 3425.     CrossRef
• Epidemiologic Features of NSCLC Gene Alterations in Hispanic Patients from Puerto Rico
  Ruifang Zheng, Zhiwei Yin, Albert Alhatem, Derek Lyle, Bei You, Andrew S. Jiang, Dongfang Liu, Zsolt Jobbagy, Qing Wang, Seena Aisner, Jie-Gen Jiang
  Cancers.2020; 12(12): 3492.     CrossRef
• Comprehensive pancancer genomic analysis reveals (RTK)-RAS-RAF-MEK as a key dysregulated pathway in cancer: Its clinical implications
  Robin Imperial, Omer M Toor, Arif Hussain, Janakiraman Subramanian, Ashiq Masood
  Seminars in Cancer Biology.2019; 54: 14.     CrossRef
• Epidermal growth factor receptor (EGFR), KRAS, and BRAF mutations in lung adenocarcinomas: A study from India
  Varsha Singh, Prerna Guleria, Prabhat Singh Malik, Anant Mohan, Sanjay Thulkar, R M Pandey, Kalpana Luthra, Sudheer Arava, Ruma Ray, Deepali Jain
  Current Problems in Cancer.2019; 43(5): 391.     CrossRef
• Clinical Validation of Coexisting Activating Mutations Within EGFR, Mitogen-Activated Protein Kinase, and Phosphatidylinositol 3-Kinase Pathways in Lung Cancers
  Federico De Marchi, Lisa Haley, Henderson Fryer, Junaid Ibrahim, Katie Beierl, Gang Zheng, Christopher D. Gocke, James R. Eshleman, Deborah Belchis, Peter Illei, Ming-Tseh Lin
  Archives of Pathology & Laboratory Medicine.2019; 143(2): 174.     CrossRef
• A sequential Monte Carlo algorithm for inference of subclonal structure in cancer
  Oyetunji E. Ogundijo, Kaiyi Zhu, Xiaodong Wang, Dimitris Anastassiou, Xiang Li
  PLOS ONE.2019; 14(1): e0211213.     CrossRef
• The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients
  Anna Rachiglio, Francesca Fenizia, Maria Piccirillo, Domenico Galetta, Lucio Crinò, Bruno Vincenzi, Emiddio Barletta, Carmine Pinto, Francesco Ferraù, Matilde Lambiase, Agnese Montanino, Cristin Roma, Vienna Ludovini, Elisabetta Montagna, Antonella De Luc
  Cancers.2019; 11(3): 341.     CrossRef
• Concurrent Driver Gene Mutations as Negative Predictive Factors in Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer
  Minjiang Chen, Yan Xu, Jing Zhao, Wei Zhong, Li Zhang, Yalan Bi, Mengzhao Wang
  EBioMedicine.2019; 42: 304.     CrossRef
• Anaplastic Lymphoma Kinase (ALK)-positive Tumors
  Rohan Gupta, Idoroenyi Amanam, Syed Rahmanuddin, Isa Mambetsariev, Yingyu Wang, Charity Huang, Karen Reckamp, Lalit Vora, Ravi Salgia
  American Journal of Clinical Oncology.2019; 42(4): 337.     CrossRef
• Clinical features and therapeutic options in non‐small cell lung cancer patients with concomitant mutations of EGFR, ALK, ROS1, KRAS or BRAF
  Xibin Zhuang, Chao Zhao, Jiayu Li, Chunxia Su, Xiaoxia Chen, Shengxiang Ren, Xuefei Li, Caicun Zhou
  Cancer Medicine.2019; 8(6): 2858.     CrossRef
• Intrinsic resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance
  Santoni-Rugiu, Melchior, Urbanska, Jakobsen, Stricker, Grauslund, Sørensen
  Cancers.2019; 11(7): 923.     CrossRef
• Clinical outcome of treatment of metastatic non-small cell lung cancer in patients harboring uncommon EGFR mutation
  J. Chantharasamee, N. Poungvarin, P. Danchaivijitr, S. Techawatanawanna
  BMC Cancer.2019;[Epub]     CrossRef
• Deregulated lncRNA expression profile in the mouse lung adenocarcinomas with KRAS‐G12D mutation and P53 knockout
  Meiqin Zhang, Nan Jiang, Renjie Cui, Sichen Du, Huayuan Ou, Tinglan Chen, Runsheng Ge, Duan Ma, Jin Zhang
  Journal of Cellular and Molecular Medicine.2019; 23(10): 6978.     CrossRef
• Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion Probes
  Erica K. Barnell, Adam Waalkes, Matt C. Mosior, Kelsi Penewit, Kelsy C. Cotto, Arpad M. Danos, Lana M. Sheta, Katie M. Campbell, Kilannin Krysiak, Damian Rieke, Nicholas C. Spies, Zachary L. Skidmore, Colin C. Pritchard, Todd A. Fehniger, Ravindra Uppalur
  JCO Clinical Cancer Informatics.2019; (3): 1.     CrossRef
• EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma
  Maria Colombino, Panagiotis Paliogiannis, Antonio Cossu, Davide Adriano Santeufemia, Maria Cristina Sini, Milena Casula, Grazia Palomba, Antonella Manca, Marina Pisano, Valentina Doneddu, Giuseppe Palmieri
  BMC Pulmonary Medicine.2019;[Epub]     CrossRef
• Concomitant Presence of EGFR and ALK Fusion Gene Mutation in Adenocarcinoma of Lung: A Case Report and Review of the Literature
  Nishitha Thumallapally, Hana Yu, Mohammad Farhan, Uroosa Ibrahim, Maricel Odiami
  Journal of Pharmacy Practice.2018; 31(2): 244.     CrossRef
• Double Trouble: A Case Series on Concomitant Genetic Aberrations in NSCLC
  Nele Van Der Steen, Yves Mentens, Marc Ramael, Leticia G. Leon, Paul Germonpré, Jose Ferri, David R. Gandara, Elisa Giovannetti, Godefridus J. Peters, Patrick Pauwels, Christian Rolfo
  Clinical Lung Cancer.2018; 19(1): 35.     CrossRef
• KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target
  Marta Román, Iosune Baraibar, Inés López, Ernest Nadal, Christian Rolfo, Silvestre Vicent, Ignacio Gil-Bazo
  Molecular Cancer.2018;[Epub]     CrossRef
• Pulmonary Adenocarcinoma, Harboring Both an EGFR Mutation and ALK Rearrangement, Presenting a Stable Disease to Erlotinib and a Partial Response to Alectinib
  Akira Yokoyama, Atsuhisa Tamura, Kazuko Miyakawa, Kei Kusaka, Masahiro Shimada, Takashi Hirose, Hirotoshi Matsui, Masashi Kitani, Akira Hebisawa, Ken Ohta
  Internal Medicine.2018; 57(16): 2377.     CrossRef
• Long-term survival with erlotinib in advanced lung adenocarcinoma harboring synchronous EGFR G719S and KRAS G12C mutations
  Biagio Ricciuti, Sara Baglivo, Vienna Ludovini, Angelo Sidoni, Giulio Metro, Marta Brambilla, Annamaria Siggillino, Maria Sole Reda, Alberto Rebonato, Daniele Maiettini, Rita Chiari
  Lung Cancer.2018; 120: 70.     CrossRef
• Concomitant driver mutations in advanced EGFR-mutated non-small-cell lung cancer and their impact on erlotinib treatment
  Jan Nyrop Jakobsen, Eric Santoni-Rugiu, Morten Grauslund, Linea Melchior, Jens Benn Sørensen
  Oncotarget.2018; 9(40): 26195.     CrossRef
• Implications of KRAS mutations in acquired resistance to treatment in NSCLC
  Marzia Del Re, Eleonora Rofi, Giuliana Restante, Stefania Crucitta, Elena Arrigoni, Stefano Fogli, Massimo Di Maio, Iacopo Petrini, Romano Danesi
  Oncotarget.2018; 9(5): 6630.     CrossRef
• Alk Immunohistochemistry is Highly Sensitive and Specific for the Detection of Alk Translocated Lung Adenocarcinomas: Lessons from An Audit of Lung Cancer Molecular Testing
  YC Kheng, K Walsh, L Williams, WA Wallace, DJ Harrison, A Oniscu
  Journal of the Royal College of Physicians of Edinburgh.2018; 48(1): 20.     CrossRef
• Targeting KRAS mutated non-small cell lung cancer: A history of failures and a future of hope for a diverse entity
  Alexios Matikas, Dimitrios Mistriotis, Vasilios Georgoulias, Athanasios Kotsakis
  Critical Reviews in Oncology/Hematology.2017; 110: 1.     CrossRef
• Clinical Outcome of ALK -Positive Non–Small Cell Lung Cancer (NSCLC) Patients with De Novo EGFR or KRAS Co-Mutations Receiving Tyrosine Kinase Inhibitors (TKIs)
  Sabine Schmid, Oliver Gautschi, Sacha Rothschild, Michael Mark, Patrizia Froesch, Dirk Klingbiel, Hermann Reichegger, Wolfram Jochum, Joachim Diebold, Martin Früh
  Journal of Thoracic Oncology.2017; 12(4): 681.     CrossRef
• EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathology
  Vincent Thomas De Montpréville, Maria-Rosa Ghigna, Ludovic Lacroix, Antoinette Lemoine, Benjamin Besse, Olaf Mercier, Élie Fadel, Peter Dorfmuller, Thierry Le Chevalier
  Pathology - Research and Practice.2017; 213(7): 793.     CrossRef
• MET Exon 14 Skipping Mutations in Lung Adenocarcinoma: Clinicopathologic Implications and Prognostic Values
  Geun Dong Lee, Seung Eun Lee, Doo-Yi Oh, Dan-bi Yu, Hae Min Jeong, Jooseok Kim, Sungyoul Hong, Hun Soon Jung, Ensel Oh, Ji-Young Song, Mi-Sook Lee, Mingi Kim, Kyungsoo Jung, Jhingook Kim, Young Kee Shin, Yoon-La Choi, Hyeong Ryul Kim
  Journal of Thoracic Oncology.2017; 12(8): 1233.     CrossRef
• Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02–14 Study)
  Jean-Bernard Auliac, Isabelle Monnet, Catherine Dubos-Arvis, Anne Marie Chiappa, Nathalie Baize, Suzana Bota, Alain Vergnenegre, Helene Doubre, Chrystele Locher, Acya Bizieux, Gilles Robinet, Christos Chouaid
  Targeted Oncology.2017; 12(6): 833.     CrossRef
• Concomitant EML4-ALK rearrangement and EGFR mutation in non-small cell lung cancer patients: a literature review of 100 cases
  Giuseppe Lo Russo, Martina Imbimbo, Giulia Corrao, Claudia Proto, Diego Signorelli, Milena Vitali, Monica Ganzinelli, Laura Botta, Nicoletta Zilembo, Filippo de Braud, Marina Chiara Garassino
  Oncotarget.2017; 8(35): 59889.     CrossRef
• Management of non-small cell lung cancer in the era of personalized medicine
  Gaetano Rocco, Alessandro Morabito, Alessandra Leone, Paolo Muto, Francesco Fiore, Alfredo Budillon
  The International Journal of Biochemistry & Cell Biology.2016; 78: 173.     CrossRef
• A long-term survivor of non-small-cell lung cancer harboring concomitant EGFR mutation and ALK translocation
  Fumio Imamura, Takako Inoue, Madoka Kimura, Kazumi Nishino, Toru Kumagai
  Respiratory Medicine Case Reports.2016; 19: 137.     CrossRef

Citations

Citations to this article as recorded by  

• Metástasis tumor a tumor en pulmón: reporte de tres casos y revisión de la literatura
  Paula Cristina Castro Quiroga, Blanca Viviana Fajardo Idrobo, Diana Marcela Caicedo Ruiz, Julieth Alexandra Franco Mira, Carlos Andrés Carvajal Fierro, Alfredo Ernesto Romero Rojas, Rafael Santiago Parra Medina
  Revista Colombiana de Cancerología.2023; 27(1): 107.     CrossRef
• Benign Neurofibroma/Schwannoma Hybrid Peripheral Nerve Sheath Tumor of the Ulnar Nerve Harboring a Metastatic Papillary Thyroid Carcinoma Deposit: A Case Report of Tumor-to-Tumor Metastasis
  Juan M. Colazo, Alexander N. Perez, Anthony D. Judice, Julia Quirion, Carlos N. Prieto-Granada, Ginger E. Holt, Samir Sami Amr
  Case Reports in Pathology.2022; 2022: 1.     CrossRef
• A case of colorectal cancer with intratumoral metastasis to primary lung cancer
  Yasushi Cho, Mitsuhito Kaji, Shunsuke Nomura, Yusuke Motohashi, Masaaki Sato, Motoya Takeuchi
  The Journal of the Japanese Association for Chest Surgery.2021; 35(5): 576.     CrossRef
• Tumor-to-tumor metastasis: metastatic invasive lobular carcinoma of the breast within adenocarcinoma of the lung
  Myoung Jae Kang, Ae Ri An, Myoung Ja Chung, Kyoung Min Kim
  Journal of Pathology and Translational Medicine.2020; 54(2): 188.     CrossRef
• Metastatic Renal Cell Neoplasm Within a Papillary Thyroid Carcinoma as Incidental Finding in an Asymptomatic Patient: a Case Report
  Maria-Rosa Bella-Cueto, Mireia Pascua-Solé, Albert Cano-Palomares, M. Àngels Cabezuelo-Hernandez, Maria-Rosa Escoda-Giralt, Santiago Barcons-Vilaplana, Paula Serret-Miralles, Carmen Caral-Vanaclocha, Xavier Guirao-Garriga, Joan Prats-Lopez, Meritxell Meda
  SN Comprehensive Clinical Medicine.2020; 2(7): 978.     CrossRef
• Squamous cell carcinoma of the lung and pulmonary metastasis of papillary thyroid carcinoma: a case report
  Arya Aminorroaya, Mohsen Khoshniatnikoo, Hossein Farrokhpour, Jamshid Vafaeimanesh, Mohammad Bagherzadeh
  Journal of Medical Case Reports.2019;[Epub]     CrossRef
• Prostatic adenocarcinoma (PCa) metastasizing to renal cell carcinoma (RCC) with periureteral tumor deposit: A case of tumor-to-tumor metastasis (TTM)
  Jenissa Amor Dionisio Arceño, Jonathan Salcedo Mendoza, Josefino Cortez Castillo, Jeffrey Santos So
  Human Pathology: Case Reports.2017; 8: 27.     CrossRef
• Dual malignancy in a thyroid; papillary thyroid carcinoma and small lymphocytic lymphoma; a report of a case with a cyto‐histologic correlation
  Omar I. Ahmed, Ziyan T. Salih
  Diagnostic Cytopathology.2017; 45(9): 851.     CrossRef
• Reactivity of thyroid papillary carcinoma cells to thyroid stimulating hormone-dominated endocrine therapy
  Yuqin Ma, Xia Zhang, Yutao Wang
  Oncology Letters.2017;[Epub]     CrossRef